BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 19684636)

  • 1. Positron emission tomography in the diagnosis and therapeutic monitoring of post-transplant lymphoproliferative disorder after cord blood transplantation.
    Kataoka K; Seo S; Ota S; Takahashi T; Kurokawa M
    Bone Marrow Transplant; 2010 Mar; 45(3):610-2. PubMed ID: 19684636
    [No Abstract]   [Full Text] [Related]  

  • 2. PET/CT staging and response evaluation of post-transplantation lymphoproliferative disease (PTLD).
    Chowdhury FU; Sheerin F; Bradley KM; Gleeson FV
    Clin Nucl Med; 2009 Jun; 34(6):386-7. PubMed ID: 19487854
    [No Abstract]   [Full Text] [Related]  

  • 3. Assessment of cellular origin and EBV status in a PTLD after double cord blood transplantation.
    Reddiconto G; Chiusolo P; Fiorini A; Farina G; Laurenti L; Martini M; Marchetti S; Fadda G; Leone G; Sica S
    Leukemia; 2007 Dec; 21(12):2552-4. PubMed ID: 17597809
    [No Abstract]   [Full Text] [Related]  

  • 4. Posttransplant lymphoproliferative disorder in a lung transplant recipient.
    Tamai K; Koyama T; Saga T; Umeoka S; Aoyama A; Hanaoka N; Fukuse T; Wada H; Tachibana M; Togashi K
    J Thorac Imaging; 2005 Nov; 20(4):280-3. PubMed ID: 16282905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow necrosis complicating post-transplant lymphoproliferative disorder: resolution with rituximab.
    Rossi D; Ramponi A; Franceschetti S; Stratta P; Gaidano G
    Leuk Res; 2008 May; 32(5):829-34. PubMed ID: 18036657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDG PET/CT Findings of the Recurrent Posttransplantation Lymphoproliferative Disorder in a Pediatric Liver Transplant Recipient With Right Leg Pain as the Only Complaint.
    Bai X; Yang H; Zhuang H
    Clin Nucl Med; 2015 Oct; 40(10):832-4. PubMed ID: 26098286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of post-transplant lymphoproliferative disorder with rituximab and radiation in a patient with second renal allograft.
    Molnar I; Keung YK
    Nephrol Dial Transplant; 2001 Oct; 16(10):2114-5. PubMed ID: 11572917
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute myeloid leukemia detected on fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography imaging in a patient with fever of unknown origin.
    Ozcan Kara P; Kara Gedik G; Sari O; Serdengecti M; Kaya B
    Rev Esp Med Nucl; 2011; 30(2):115-6. PubMed ID: 21316125
    [No Abstract]   [Full Text] [Related]  

  • 9. [Epstein-Barr virus-associated post-transplant lymphoproliferative disorder diagnosed by the episode of intestinal perforation following allogeneic hematopoietic stem cell transplantation].
    Aimoto M; Yamane T; Inoue A; Momose D; Moriguchi-Aimoto R; Wada-Inoue E; Okamoto S; Koh H; Nakane T; Takeoka Y; Akahori-Nakamae M; Nishiki-Kosaka S; Terada Y; Nakamae H; Koh KR; Nakao T; Ohsawa M; Hino M
    Rinsho Ketsueki; 2010 Dec; 51(12):1775-80. PubMed ID: 21258188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-CD20 monoclonal antibody treatment of Epstein-Barr virus-induced intrahepatic lymphoproliferative disorder following liver transplantation.
    Yedibela S; Reck T; Niedobitek G; Gramatzki M; Repp R; Hohenberger W; Ott R
    Transpl Int; 2003 Mar; 16(3):197-201. PubMed ID: 12664216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Epstein-Barr virus--associated lymphoproliferative disorder (EBV-PTLD) and pure red cell aplasia (PRCA) with Rituximab following unrelated cord blood transplantation: a case report and literature review.
    Zhu K; Chen J; Chen S
    Hematology; 2005 Oct; 10(5):365-70. PubMed ID: 16273722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient bone marrow lymphoproliferation after umbilical cord blood transplantation: exacerbated reconstitution of B-cell ontogeny in adults.
    Jerez A; Osma Mdel M; Castilla-Llorente C; Bernal A; Palacios S; Heras I; Ortuño FJ
    Am J Hematol; 2011 Jun; 86(6):518-20. PubMed ID: 21594890
    [No Abstract]   [Full Text] [Related]  

  • 13. Positron emission tomography scanning in the setting of post-transplant lymphoproliferative disorders.
    Blaes AH; Cioc AM; Froelich JW; Peterson BA; Dunitz JM
    Clin Transplant; 2009; 23(6):794-9. PubMed ID: 20447185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of post-transplant lymphoproliferative disease with rituximab].
    Jiang YJ; Wang X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):852-6. PubMed ID: 24989308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rituximab therapy and reduction of immunosuppression to rescue graft function after renal posttransplantation lymphoproliferative disorder found by macrohematuria in a pancreas and kidney transplant recipient: a case report.
    Miyagi S; Sekiguchi S; Kawagishi N; Akamatsu Y; Satoh K; Takeda I; Fukushima D; Kobayashi Y; Tokodai K; Fujimori K; Satomi S
    Transplant Proc; 2011 Nov; 43(9):3299-301. PubMed ID: 22099782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post transplant lymphoproliferative disease in pediatric solid organ transplant patients: a possible role for [18F]-FDG-PET(/CT) in initial staging and therapy monitoring.
    von Falck C; Maecker B; Schirg E; Boerner AR; Knapp WH; Klein C; Galanski M
    Eur J Radiol; 2007 Sep; 63(3):427-35. PubMed ID: 17293073
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Treglia G; Ceriani L
    Eur J Nucl Med Mol Imaging; 2020 Mar; 47(3):523-524. PubMed ID: 31485683
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful treatment of posttransplant lymphoproliferative disorder with renal graft preservation by monoclonal antibody therapy.
    Antoine C; Garnier JL; Duboust A; Bariéty J; Stevenson G; Glotz D
    Transplant Proc; 1996 Oct; 28(5):2825-6. PubMed ID: 8908082
    [No Abstract]   [Full Text] [Related]  

  • 19. Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: a retrospective analysis on 32 patients.
    Milpied N; Vasseur B; Parquet N; Garnier JL; Antoine C; Quartier P; Carret AS; Bouscary D; Faye A; Bourbigot B; Reguerre Y; Stoppa AM; Bourquard P; Hurault de Ligny B; Dubief F; Mathieu-Boue A; Leblond V
    Ann Oncol; 2000; 11 Suppl 1():113-6. PubMed ID: 10707791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDG PET/CT Findings of Polymorphic Posttransplant Lymphoproliferative Disorders in a Transplanted Kidney.
    Yang Y; Wang W; Kan Y; Liu J; Yang J
    Clin Nucl Med; 2018 Jun; 43(6):441-444. PubMed ID: 29485445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.